Navigation Links
Nonclinical and Clinical Safety Assessment of Biosimilars, New Webinar Hosted by Xtalks
Date:7/15/2013

Toronto, Canada (PRWEB) July 15, 2013

The development of Biosimilars has gained momentum in recent years due to upcoming patent expiry of first generation Biologics and increasing financial pressure on health care systems. Consequently, regulatory frameworks are evolving in various countries to guide a path for Biosimilar drug development, however, the complex nature of Biopharmaceuticals makes the demonstration of Biosimilarity with regard to quality, safety and efficacy extremely challenging.

Based on the specific aspects of Biosimilar drug development and registration, the development strategies differ significantly from the development of an innovator product that has to establish both the efficacy and safety independently from other products.

The webinar will review the current regulatory landscape and guidance for nonclinical and clinical development of Biosimilars with a focus on safety-related aspects and discuss the current challenges and future perspectives in this area.

A live Q&A with the audience will follow the main presentation. For more information, or to register for this event please go to http://xtalks.com/biosimilars-safety-assessment.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com

Contact:
Zayeeta Dasgupta, M.Sc in Life Science and Business Ma
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. PointCross Life Sciences Opens New Office in Silver Spring, Maryland for Data Standardization of Nonclinical Studies
2. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
3. Positive Clinical Study Results for BSPs HyperQ Technology
4. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
5. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
6. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
7. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
8. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
9. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
10. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
11. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2014)... Sept. 26, 2014 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic stem cell ... will hold its 2014 annual general meeting of shareholders at its ... China Tower, 1 Garden Road, Central, Hong Kong ... (8:00 a.m. U.S. Eastern Time on December 11, 2014). ...
(Date:9/26/2014)... September 26, 2014 Molecular Biology ... the cell for the regulation of cellular activity and ... interactions between genes and with its environment within the ... of new and novel therapeutic methodologies for the diagnosis, ... , On this occasion, Dr. Srinubabu Gedela, MD of ...
(Date:9/26/2014)... “Inflamax’s Clinical Data Management group is a ... this allows us to support our group in maintaining ... Johnson, Director of Data Management at Inflamax. “Being ... our Clinical Data Managers have been certified by passing ... to offering only the best services to our clients, ...
(Date:9/25/2014)... implicated in several cancers appears to play a pivotal role ... to a new study by NYU Langone Medical Center scientists. ... . , Stem cells are the perpetual adolescents of the ... can be programmed to differentiate into any mature cell type, ... understanding of their biology, however, is needed. ...
Breaking Biology Technology:China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 3NYU Langone scientists identify key factor that maintains stem cell identity 2
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) ... research group at The Institute of Cancer Research, ... combination treatment schedules,of reovirus and radiation in human ... The paper, entitled "Enhanced In vitro and In ...
... environment and holding it indefinitely in molecular-sized containers has been ... say it represents a novel method of gas storage that ... safely and efficiently. , This is a proof of concept ... just improving on a method that already exists, said U ...
... the economy is not,only heading towards a recession but ... during January. However, biotech held steady,with the Burrill Biotech ... posted a January loss of 9.9%, and the Dow, ... ride out extremely volatile capital,markets with less damage because ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy 2Rounding up gases, nano-style 2January Market Jitters Fails to Derail Biotech 2January Market Jitters Fails to Derail Biotech 3January Market Jitters Fails to Derail Biotech 4
(Date:9/29/2014)... Advocacy Awards will honor ... medical progress to improve the health and economic ... place on Wednesday, March 11, 2015, at the ... The 2015 Advocacy Award winners are ABC,s "Good ... of the Milken Institute and FasterCures; Dr. Kenneth ...
(Date:9/29/2014)... Energy Joint Genome Institute (DOE JGI), a DOE ... 32 new projects have been selected for the ... lakes to Caribbean waters, and from plant root ... in forested watersheds, the CSP 2015 projects portfolio ... be extracted. , "These projects catalyze JGI,s ...
(Date:9/29/2014)... WASHINGTON, Sept. 29, 2014 Oktoberfest is ... nothing worse than reaching for a cold ... your beer,s been skunked: chemicals have reacted ... bitter taste. This week, Reactions explains why ... do to keep your brews from going ...
Breaking Biology News(10 mins):Research!America to honor leaders in medical and health research advocacy 2Research!America to honor leaders in medical and health research advocacy 3Research!America to honor leaders in medical and health research advocacy 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 22015 DOE JGI's science portfolio delves deeper into the Earth's data mine 32015 DOE JGI's science portfolio delves deeper into the Earth's data mine 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 52015 DOE JGI's science portfolio delves deeper into the Earth's data mine 62015 DOE JGI's science portfolio delves deeper into the Earth's data mine 72015 DOE JGI's science portfolio delves deeper into the Earth's data mine 82015 DOE JGI's science portfolio delves deeper into the Earth's data mine 9
... by the University of Zaragoza (UNIZAR) started to carry out ... then they have focused on analysing the fossil remains of ... the Cantabrian region over the past 41,000 years, at the ... conservation status of the fossils have enabled the researchers to ...
... in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2009-06/kcl-nss060209.php,">Chinese . Flooding is ... globe. It is the worst natural disaster in the ... figure is expected to increase to 3.5 billion over ... that took place in China over the past decade ...
... In recent years, obesity has taken on epidemic proportions ... early death and rising health care costs. According to ... a quarter of all American adults and more than ... While recent research advances and treatment ...
Cached Biology News:Cantabrian cornice has experienced seven cooling and warming phases over past 41,000 years 2Next-generation software system for flood warning and risk analysis to be developed 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 3
... new MALDI O-TOF creates a new category ... orthogonal platform that has been licensed to ... of Manitoba. , As the first single ... and collisional cooling, the prOTOF 2000 represents ...
Rat Dermal Fibroblasts (RDF) (>500,000 cells)...
...
... The NeuroLog System is a compact, versatile & ... variety of purposes including: Intracellular, Extracellular, Transducer ... The NeuroLog Case & Power Supply unit ... Modules are not only powered by this ...
Biology Products: